Fortrea
William Reece is an accomplished biostatistics professional with extensive experience in the pharmaceutical industry. Currently serving as Director of Biostatistics and Director of Commercial Support Services at Fortrea since January 2022, William previously held the position of Director of Statistics and Pharmacokinetics at Covance from November 2007 to February 2022. Earlier in William's career, a role as Group Leader of Oncology Statistics at Eli Lilly was undertaken from 2002 to 2007. William's educational background includes a Master of Biostatistics from the University of Sydney, a PhD in Immunology from the University of Glasgow, and a Bachelor's degree in Biochemistry from the University of Oxford, complemented by a Diploma in Statistics from The Open University.
This person is not in any teams
This person is not in any offices
Fortrea
13 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.